High levels of adherence do not prevent accumulation of HIV drug resistance mutations

2003256 citationsJournal Article

Authors

David R. Bangsberg

Edwin D. Charlebois · University of California, San Francisco

Robert M. Grant · Gladstone Institutes

Mark Holodniy · VA Palo Alto Health Care System

Steven G. Deeks · San Francisco General Hospital

Sharon Perry · Stanford University

Kathleen Conroy · Stanford University

Abstract

Increasing rates of viral suppression at high levels of adherence is balanced by increasing rates of drug resistance among viremic patients. Exceptionally high levels of adherence will not prevent population levels of drug resistance.

Topics & Keywords

HIV/AIDS drug development and treatment HIV/AIDS Research and Interventions HIV Research and Treatment

UN Sustainable Development Goals

No povertyGood health and well-being

Publication Details

Published in: AIDS

Volume 17, Issue 13, pp. 1925-1932

DOI: 10.1097/00002030-200309050-00011

Field-Weighted Citation Impact: 12.13